Research Papers:

IRWRLDA: improved random walk with restart for lncRNA-disease association prediction

Xing Chen _, Zhu-Hong You, Gui-Ying Yan and Dun-Wei Gong

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:57919-57931. https://doi.org/10.18632/oncotarget.11141

Metrics: PDF 2496 views  |   HTML 5343 views  |   ?  


Xing Chen1, Zhu-Hong You2, Gui-Ying Yan3,4, Dun-Wei Gong1

1School of Information and Electrical Engineering, China University of Mining and Technology, Xuzhou, 221116, China

2School of Computer Science and Technology, China University of Mining and Technology, Xuzhou, 221116, China

3Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, 100190, China

4National Center for Mathematics and Interdisciplinary Sciences, Chinese Academy of Sciences, Beijing, 100190, China

Correspondence to:

Xing Chen, email: [email protected]

Zhu-Hong You, email: [email protected]

Keywords: lncRNAs, disease, cancer, random walk with restart

Received: January 20, 2016     Accepted: July 06, 2016     Published: August 09, 2016


In recent years, accumulating evidences have shown that the dysregulations of lncRNAs are associated with a wide range of human diseases. It is necessary and feasible to analyze known lncRNA-disease associations, predict potential lncRNA-disease associations, and provide the most possible lncRNA-disease pairs for experimental validation. Considering the limitations of traditional Random Walk with Restart (RWR), the model of Improved Random Walk with Restart for LncRNA-Disease Association prediction (IRWRLDA) was developed to predict novel lncRNA-disease associations by integrating known lncRNA-disease associations, disease semantic similarity, and various lncRNA similarity measures. The novelty of IRWRLDA lies in the incorporation of lncRNA expression similarity and disease semantic similarity to set the initial probability vector of the RWR. Therefore, IRWRLDA could be applied to diseases without any known related lncRNAs. IRWRLDA significantly improved previous classical models with reliable AUCs of 0.7242 and 0.7872 in two known lncRNA-disease association datasets downloaded from the lncRNADisease database, respectively. Further case studies of colon cancer and leukemia were implemented for IRWRLDA and 60% of lncRNAs in the top 10 prediction lists have been confirmed by recent experimental reports.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11141